NasdaqCM - Nasdaq Real Time Price USD
Coya Therapeutics, Inc. (COYA)
5.54
-0.12
(-2.12%)
As of 2:17:27 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| GROSSMAN FRED Officer | Purchase | Nov 11, 2024 | 2,710 |
| LEE ANN Director | Purchase | Aug 22, 2023 | -- |
| SNYDER DAVID S. Chief Financial Officer | Purchase | Nov 14, 2024 | 8,800 |
| SWAMINATHAN ARUN PH.D. Chief Executive Officer | Purchase | Nov 13, 2024 | 10,000 |
Related Tickers
GANX Gain Therapeutics, Inc.
1.8100
-4.23%
ACTU Actuate Therapeutics, Inc. Common stock
8.48
-1.40%
INMB INmune Bio, Inc.
7.93
+0.63%
RNXT RenovoRx, Inc.
1.3613
+1.59%
FBRX Forte Biosciences, Inc.
12.53
+2.32%
EPRX Eupraxia Pharmaceuticals Inc.
3.9885
+0.21%
NVCT Nuvectis Pharma, Inc.
8.87
-1.66%
RPTX Repare Therapeutics Inc.
1.4300
-3.38%
APS.TO Aptose Biosciences Inc.
2.3600
-2.48%
CUE Cue Biopharma, Inc.
0.6345
+0.14%